BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35255831)

  • 1. Nucleolar localization of the ErbB3 receptor as a new target in glioblastoma.
    Tagliaferro M; Rosa P; Bellenchi GC; Bastianelli D; Trotta R; Tito C; Fazi F; Calogero A; Ponti D
    BMC Mol Cell Biol; 2022 Mar; 23(1):13. PubMed ID: 35255831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.
    Dong Z; Zhu C; Zhan Q; Jiang W
    Oncotarget; 2017 Feb; 8(8):13240-13252. PubMed ID: 28099941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells.
    Ratchford AM; Baker OJ; Camden JM; Rikka S; Petris MJ; Seye CI; Erb L; Weisman GA
    J Biol Chem; 2010 Mar; 285(10):7545-55. PubMed ID: 20064929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells.
    Koumakpayi IH; Le Page C; Delvoye N; Saad F; Mes-Masson AM
    Mol Carcinog; 2011 Nov; 50(11):901-12. PubMed ID: 21438025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines.
    Carrasco-García E; Saceda M; Grasso S; Rocamora-Reverte L; Conde M; Gómez-Martínez A; García-Morales P; Ferragut JA; Martínez-Lacaci I
    Exp Cell Res; 2011 Jun; 317(10):1476-89. PubMed ID: 21439954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
    Lafita-Navarro MC; Venkateswaran N; Kilgore JA; Kanji S; Han J; Barnes S; Williams NS; Buszczak M; Burma S; Conacci-Sorrell M
    PLoS Genet; 2020 Nov; 16(11):e1009117. PubMed ID: 33201894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional organization of the nucleolus in proliferating plant cells.
    Medina FJ; Cerdido A; de Cárcer G
    Eur J Histochem; 2000; 44(2):117-31. PubMed ID: 10968360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the UBF gene induces aberrant somatic nucleolar bodies and disrupts embryo nucleolar precursor bodies.
    Hamdane N; Tremblay MG; Dillinger S; Stefanovsky VY; Németh A; Moss T
    Gene; 2017 May; 612():5-11. PubMed ID: 27614293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the nucleolus in the CAG RNA-mediated toxicity.
    Tsoi H; Chan HY
    Biochim Biophys Acta; 2014 Jun; 1842(6):779-84. PubMed ID: 24269666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis.
    Lafita-Navarro MC; Blanco R; Mata-Garrido J; Liaño-Pons J; Tapia O; García-Gutiérrez L; García-Alegría E; Berciano MT; Lafarga M; León J
    Oncotarget; 2016 Oct; 7(43):69536-69548. PubMed ID: 27588501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar TRF2 attenuated nucleolus stress-induced HCC cell-cycle arrest by altering rRNA synthesis.
    Yuan F; Xu C; Li G; Tong T
    Cell Death Dis; 2018 May; 9(5):518. PubMed ID: 29725012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolus and Nucleolar Stress: From Cell Fate Decision to Disease Development.
    Hua L; Yan D; Wan C; Hu B
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.
    Alvarado D; Ligon GF; Lillquist JS; Seibel SB; Wallweber G; Neumeister VM; Rimm DL; McMahon G; LaVallee TM
    PLoS One; 2017; 12(7):e0181356. PubMed ID: 28723928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and epigenetics of nucleoli in comparison with non-nucleolar compartments.
    Bártová E; Horáková AH; Uhlírová R; Raska I; Galiová G; Orlova D; Kozubek S
    J Histochem Cytochem; 2010 May; 58(5):391-403. PubMed ID: 20026667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.
    Frolov A; Schuller K; Tzeng CW; Cannon EE; Ku BC; Howard JH; Vickers SM; Heslin MJ; Buchsbaum DJ; Arnoletti JP
    Cancer Biol Ther; 2007 Apr; 6(4):548-54. PubMed ID: 17457047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma.
    Kofuji S; Hirayama A; Eberhardt AO; Kawaguchi R; Sugiura Y; Sampetrean O; Ikeda Y; Warren M; Sakamoto N; Kitahara S; Yoshino H; Yamashita D; Sumita K; Wolfe K; Lange L; Ikeda S; Shimada H; Minami N; Malhotra A; Morioka S; Ban Y; Asano M; Flanary VL; Ramkissoon A; Chow LML; Kiyokawa J; Mashimo T; Lucey G; Mareninov S; Ozawa T; Onishi N; Okumura K; Terakawa J; Daikoku T; Wise-Draper T; Majd N; Kofuji K; Sasaki M; Mori M; Kanemura Y; Smith EP; Anastasiou D; Wakimoto H; Holland EC; Yong WH; Horbinski C; Nakano I; DeBerardinis RJ; Bachoo RM; Mischel PS; Yasui W; Suematsu M; Saya H; Soga T; Grummt I; Bierhoff H; Sasaki AT
    Nat Cell Biol; 2019 Aug; 21(8):1003-1014. PubMed ID: 31371825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wnt/β-Catenin Pathway is Activated as a Novel Nucleolar Stress Response.
    Dannheisig DP; Bächle J; Tasic J; Keil M; Pfister AS
    J Mol Biol; 2021 Jan; 433(2):166719. PubMed ID: 33221336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological AMP kinase activators target the nucleolar organization and control cell proliferation.
    Kodiha M; Salimi A; Wang YM; Stochaj U
    PLoS One; 2014; 9(1):e88087. PubMed ID: 24498249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRM1 and its ribosome export adaptor NMD3 localize to the nucleolus and affect rRNA synthesis.
    Bai B; Moore HM; Laiho M
    Nucleus; 2013; 4(4):315-25. PubMed ID: 23782956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells.
    Ueno Y; Sakurai H; Tsunoda S; Choo MK; Matsuo M; Koizumi K; Saiki I
    Int J Cancer; 2008 Jul; 123(2):340-347. PubMed ID: 18398842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.